NextCure, Inc.

BELTSVILLE, MD How do I update this listing?

Nextcure is based out of Beltsville. NextCure, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on discovering and developing next generation immunomedicines for cancer and other diseases. NextCure serves health care industry. The firm last filed a Form D notice of exempt offering of securities on 2018-11-19. The notice included securities offered of Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security,Other

Create Email Alert

Contact Info

nextcure, inc.
9000 VIRGINIA MANOR ROAD, SUITE 200
BELTSVILLE MD    20705

Business Phone: 240-399-4900
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Form 4 - Recent Insider Transactions

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2018-11-19 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security,Other 93,432,873 93,432,873 0
2016-01-11 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security,Other 67,000,000 15,000,000 52,000,000
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ASHER RUBIN subscription required
    EXECUTIVE OFFICER
CAROLYN GREEN subscription required
    DIRECTOR
CHAU Q. KHUONG subscription required
    DIRECTOR
DAVID KABAKOFF subscription required
    DIRECTOR
ELAINE JONES subscription required
    DIRECTOR
JUDITH LI subscription required
    DIRECTOR
KEVIN N. HELLER subscription required
    EXECUTIVE OFFICER
MICHAEL RICHMAN subscription required
    EXECUTIVE OFFICER DIRECTOR
MICHAEL YI subscription required
    DIRECTOR
STELLA XU subscription required
    DIRECTOR
STEVEN COBOURN subscription required
    EXECUTIVE OFFICER
TIM SHANNON subscription required
    DIRECTOR

Elevate your investments